Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Invested Capital (2016 - 2025)

Mimedx (MDXG) has disclosed Invested Capital for 15 consecutive years, with $274.5 million as the latest value for Q4 2025.

  • Quarterly Invested Capital rose 29.44% to $274.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $274.5 million through Dec 2025, up 29.44% year-over-year, with the annual reading at $274.5 million for FY2025, 29.44% up from the prior year.
  • Invested Capital hit $274.5 million in Q4 2025 for Mimedx, up from $238.9 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $274.5 million in Q4 2025 to a low of $29.0 million in Q3 2022.
  • Historically, Invested Capital has averaged $113.9 million across 5 years, with a median of $49.3 million in 2021.
  • Biggest five-year swings in Invested Capital: crashed 59.08% in 2021 and later surged 529.67% in 2023.
  • Year by year, Invested Capital stood at $48.2 million in 2021, then tumbled by 36.51% to $30.6 million in 2022, then soared by 529.67% to $192.7 million in 2023, then increased by 10.06% to $212.1 million in 2024, then grew by 29.44% to $274.5 million in 2025.
  • Business Quant data shows Invested Capital for MDXG at $274.5 million in Q4 2025, $238.9 million in Q3 2025, and $217.9 million in Q2 2025.